AriBioLab Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,233	9,775	10,092	5,906	2,386	3,955
Short-Term Investments	13,490	13,490	22,550	32,990	55,377	47,500
Trading Asset Securities	409.78	406.79	7,465	-	-	10,095
Cash & Short-Term Investments	16,133	23,672	40,107	38,896	57,763	61,550
Cash Growth	-57.18%	-40.98%	3.11%	-32.66%	-6.15%	147.92%
Accounts Receivable	-0	-0	-0	0	-0	-0
Other Receivables	325.28	468.61	399.87	453.87	607.81	266.9
Receivables	325.28	468.61	399.87	453.87	607.8	266.9
Prepaid Expenses	87.6	77.23	106.63	94.23	117.1	12.94
Other Current Assets	2,613	2,661	3,977	3,042	429	17.07
Total Current Assets	19,159	26,879	44,590	42,486	58,917	61,847
Property, Plant & Equipment	762.29	842.79	1,120	1,644	1,543	1,032
Long-Term Investments	1,612	1,612	1,069	674.6	440	2,300
Other Intangible Assets	245.14	229.85	174.67	43.58	39.91	21.77
Long-Term Accounts Receivable	0	0	0	0	0	0
Other Long-Term Assets	211.83	217.88	294.39	270.9	129.08	112.5
Total Assets	21,991	29,782	47,248	45,119	61,069	65,313
Accrued Expenses	-	105.37	129.31	146.74	77.43	60.77
Short-Term Debt	5,915	8,841	4,950	-	23,240	20,717
Current Portion of Leases	-	-	8.35	162.92	381.21	112.8
Other Current Liabilities	4,628	7,239	4,526	500.53	3,090	3,816
Total Current Liabilities	10,544	16,185	9,613	810.18	26,789	24,706
Long-Term Debt	-	-	4,627	3,975	-	-
Long-Term Leases	-	-	3.81	188.65	16.53	16.14
Pension & Post-Retirement Benefits	1,733	1,625	1,620	1,203	882.35	737.9
Other Long-Term Liabilities	121.86	112.64	3,662	3,525	15.09	237.52
Total Liabilities	12,399	17,923	19,526	9,702	27,703	25,698
Common Stock	13,433	13,433	13,412	13,366	13,215	13,215
Additional Paid-In Capital	79,723	79,870	79,687	76,782	72,576	72,576
Retained Earnings	-84,013	-81,939	-65,920	-55,457	-53,615	-46,921
Comprehensive Income & Other	449.22	495.63	542.97	725.68	1,190	745.6
Shareholders' Equity	9,592	11,859	27,722	35,417	33,366	39,615
Total Liabilities & Equity	21,991	29,782	47,248	45,119	61,069	65,313
Total Debt	5,915	8,841	9,589	4,327	23,638	20,846
Net Cash (Debt)	10,218	14,831	30,518	34,569	34,125	40,704
Net Cash Growth	-62.95%	-51.40%	-11.72%	1.30%	-16.16%	579.94%
Net Cash Per Share	380.07	552.25	1137.84	1304.13	1290.78	1745.71
Filing Date Shares Outstanding	26.93	26.87	26.82	26.73	26.43	26.43
Total Common Shares Outstanding	26.93	26.87	26.82	26.73	26.43	26.43
Working Capital	8,616	10,694	34,977	41,676	32,128	37,141
Book Value Per Share	356.21	441.43	1033.46	1324.89	1262.45	1498.91
Tangible Book Value	9,347	11,629	27,548	35,373	33,326	39,593
Tangible Book Value Per Share	347.11	432.87	1026.95	1323.26	1260.94	1498.09
Land	95.09	95.09	95.09	95.09	95.09	95.09
Buildings	402.68	402.68	402.68	402.68	402.68	402.68
Machinery	2,209	2,205	2,086	1,933	1,622	1,079